" /> Bortezomib/Cyclophosphamide/Daratumumab/Dexamethasone Regimen - CISMeF





Preferred Label : Bortezomib/Cyclophosphamide/Daratumumab/Dexamethasone Regimen;

NCIt synonyms : Bortezomib/Cyclophosphamide/Dexamethasone Plus Daratumumab; Bortezomib-Cyclophosphamide-Dexamethasone Plus Daratumumab; Bortezomib/Cyclophosphamide/Dexamethasone Plus Daratumumab Regimen; CyBorD-Daratumumab; VCD-Daratumumab; Bortezomib/Cyclophosphamide/Dexamethasone Plus Darzalex; Bortezomib/Cyclophosphamide/Daratumumab/Dexamethasone; Bortezomib-Cyclophosphamide-Daratumumab-Dexamethasone; Daratumumab-CyBorD; Bortezomib-Cyclophosphamide-Daratumumab-Dexamethasone Regimen;

NCIt definition : A regimen consisting of bortezomib, cyclophosphamide, daratumumab and dexamethasone that can be used for the treatment of plasma cell (multiple) myeloma and systemic light chain amyloidosis.;

NCI Metathesaurus CUI : CL1664477;

Détails


Vous pouvez consulter :


Nous contacter.
29/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.